Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Assessing medical technologies [[electronic resource] ] : report of a study / / by a committee of the Institute of Medicine, Division of Health Sciences Policy, Division of Health Promotion and Disease Prevention
| Assessing medical technologies [[electronic resource] ] : report of a study / / by a committee of the Institute of Medicine, Division of Health Sciences Policy, Division of Health Promotion and Disease Prevention |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, c1985 |
| Descrizione fisica | 1 online resource (592 p.) |
| Disciplina | 610/.28 |
| Soggetto topico |
Medical care - United States
Technology assessment - United States Medical technology - United States - Evaluation Medical care Technology assessment Medical technology - Evaluation |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-22193-3
9786610221936 0-309-56306-2 0-585-14244-0 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Assessing Medical Technologies""; ""Copyright""; ""Acknowledgments""; ""Preface""; ""PROCEDURE FOR THE STUDY""; ""AUDIENCE FOR THE STUDY""; ""Contents""; ""Summary""; ""THE SCOPE OF U.S. MEDICAL TECHNOLOGY ASSESSMENT""; ""Varieties and Expense of Assessment""; ""Federal Government""; ""Drug Industry""; ""Medical Device Industry""; ""Other Private Sector Assessment Activities""; ""Lags in Assessment""; ""Recommendations""; ""METHODS OF MEDICAL TECHNOLOGY ASSESSMENT""; ""EFFECTS OF EVALUATION ON DIFFUSION OF TECHNOLOGY""; ""Diffusion and Its Determinants""
""Types of Evaluation That Precede Accepted Medical Practice""""Recommendations""; ""REIMBURSEMENT AND TECHNOLOGY ASSESSMENT""; ""Assessment in the New Era of Cost Containment""; ""Paying for Technology Assessment""; ""Recommendations""; ""MEDICAL TECHNOLOGY ASSESSMENT ABROAD""; ""Recommendations""; ""CONCLUSIONS AND RECOMMENDATIONS""; ""The Challenge""; ""Key Functions for Assessment""; ""Building a System""; ""Financing""; ""Recommendations""; ""1 Introduction""; ""POLIO""; ""SURGICAL PROCEDURE""; ""EXAMPLES OF TECHNOLOGY ASSESSMENT""; ""Electronic Fetal Monitoring"" ""Computed Tomography Scanning""""Drug Treatment for Hypertension""; ""Hysterectomy""; ""Medical Information System""; ""SOME LESSONS FROM THE EXAMPLES""; ""COMPREHENSIVE TECHNOLOGY ASSESSMENT""; ""DIFFERENT PARTIES, DIFFERENT AIMS IN ASSESSMENTS""; ""REFERENCES""; ""2 The Scope of U.S. Medical Technology Assessment""; ""AN OVERVIEW""; ""VARIETIES OF MEDICAL TECHNOLOGY ASSESSMENT""; ""NATIONAL EXPENDITURES FOR HEALTH RESEARCH AND DEVELOPMENT, CLINICAL TRIALS, AND TECHNOLOGY ASSESSMENT""; ""FEDERAL GOVERNMENT""; ""National Institutes of Health""; ""Office of Medical Applications of Research"" ""Food and Drug Administration""""Office of Technology Assessment""; ""Prospective Payment Assessment Commission""; ""Health Care Financing Administration""; ""National Center for Health Services Research and Health Care Technology Assessment""; ""Office of Health Technology Assessment""; ""National Center for Health Statistics""; ""Veterans Administration""; ""Centers for Disease Control""; ""Department of Defense""; ""DRUG INDUSTRY""; ""Drug Industry Research and Development""; ""Assessment of Drugs""; ""Expenditures for Drug Assessment""; ""MEDICAL DEVICE INDUSTRY"" ""Medical Device Industry Research and Development""""Assessment of Medical Devices""; ""Expenditures for Medical Device Assessment""; ""OTHER PRIVATE SECTOR ASSESSMENT ACTIVITIES""; ""Insurers""; ""Medical Associations""; ""Policy Research Groups""; ""Industry Associations""; ""Provider Institutions""; ""Academic Institutions""; ""Employers""; ""CONCLUSIONS""; ""RECOMMENDATIONS""; ""Assessment Concerns""; ""Coordination of Assessment Information""; ""Responsibility for Conduct of Assessments""; ""Evaluation of Assessment Programs""; ""Financial Support for Medical Technology Assessment"" ""Amount of Support"" |
| Record Nr. | UNINA-9910455416503321 |
| Washington, D.C., : National Academy Press, c1985 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Assessing medical technologies : report of a study / / by a committee of the Institute of Medicine, Division of Health Sciences Policy, Division of Health Promotion and Disease Prevention
| Assessing medical technologies : report of a study / / by a committee of the Institute of Medicine, Division of Health Sciences Policy, Division of Health Promotion and Disease Prevention |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, c1985 |
| Descrizione fisica | 1 online resource (592 pages) |
| Disciplina | 610/.28 |
| Soggetto topico |
Medical care - United States
Technology assessment - United States Medical technology - United States - Evaluation Medical care Technology assessment Medical technology - Evaluation |
| ISBN |
1-280-22193-3
9786610221936 0-309-56306-2 0-585-14244-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Assessing Medical Technologies""; ""Copyright""; ""Acknowledgments""; ""Preface""; ""PROCEDURE FOR THE STUDY""; ""AUDIENCE FOR THE STUDY""; ""Contents""; ""Summary""; ""THE SCOPE OF U.S. MEDICAL TECHNOLOGY ASSESSMENT""; ""Varieties and Expense of Assessment""; ""Federal Government""; ""Drug Industry""; ""Medical Device Industry""; ""Other Private Sector Assessment Activities""; ""Lags in Assessment""; ""Recommendations""; ""METHODS OF MEDICAL TECHNOLOGY ASSESSMENT""; ""EFFECTS OF EVALUATION ON DIFFUSION OF TECHNOLOGY""; ""Diffusion and Its Determinants""
""Types of Evaluation That Precede Accepted Medical Practice"" ""Recommendations""; ""REIMBURSEMENT AND TECHNOLOGY ASSESSMENT""; ""Assessment in the New Era of Cost Containment""; ""Paying for Technology Assessment""; ""Recommendations""; ""MEDICAL TECHNOLOGY ASSESSMENT ABROAD""; ""Recommendations""; ""CONCLUSIONS AND RECOMMENDATIONS""; ""The Challenge""; ""Key Functions for Assessment""; ""Building a System""; ""Financing""; ""Recommendations""; ""1 Introduction""; ""POLIO""; ""SURGICAL PROCEDURE""; ""EXAMPLES OF TECHNOLOGY ASSESSMENT""; ""Electronic Fetal Monitoring"" ""Computed Tomography Scanning"" ""Drug Treatment for Hypertension""; ""Hysterectomy""; ""Medical Information System""; ""SOME LESSONS FROM THE EXAMPLES""; ""COMPREHENSIVE TECHNOLOGY ASSESSMENT""; ""DIFFERENT PARTIES, DIFFERENT AIMS IN ASSESSMENTS""; ""REFERENCES""; ""2 The Scope of U.S. Medical Technology Assessment""; ""AN OVERVIEW""; ""VARIETIES OF MEDICAL TECHNOLOGY ASSESSMENT""; ""NATIONAL EXPENDITURES FOR HEALTH RESEARCH AND DEVELOPMENT, CLINICAL TRIALS, AND TECHNOLOGY ASSESSMENT""; ""FEDERAL GOVERNMENT""; ""National Institutes of Health""; ""Office of Medical Applications of Research"" ""Food and Drug Administration"" ""Office of Technology Assessment""; ""Prospective Payment Assessment Commission""; ""Health Care Financing Administration""; ""National Center for Health Services Research and Health Care Technology Assessment""; ""Office of Health Technology Assessment""; ""National Center for Health Statistics""; ""Veterans Administration""; ""Centers for Disease Control""; ""Department of Defense""; ""DRUG INDUSTRY""; ""Drug Industry Research and Development""; ""Assessment of Drugs""; ""Expenditures for Drug Assessment""; ""MEDICAL DEVICE INDUSTRY"" ""Medical Device Industry Research and Development"" ""Assessment of Medical Devices""; ""Expenditures for Medical Device Assessment""; ""OTHER PRIVATE SECTOR ASSESSMENT ACTIVITIES""; ""Insurers""; ""Medical Associations""; ""Policy Research Groups""; ""Industry Associations""; ""Provider Institutions""; ""Academic Institutions""; ""Employers""; ""CONCLUSIONS""; ""RECOMMENDATIONS""; ""Assessment Concerns""; ""Coordination of Assessment Information""; ""Responsibility for Conduct of Assessments""; ""Evaluation of Assessment Programs""; ""Financial Support for Medical Technology Assessment""; ""Amount of Support"" |
| Record Nr. | UNINA-9910778711403321 |
| Washington, D.C., : National Academy Press, c1985 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Assessing medical technologies : report of a study / / by a committee of the Institute of Medicine, Division of Health Sciences Policy, Division of Health Promotion and Disease Prevention
| Assessing medical technologies : report of a study / / by a committee of the Institute of Medicine, Division of Health Sciences Policy, Division of Health Promotion and Disease Prevention |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, c1985 |
| Descrizione fisica | 1 online resource (592 pages) |
| Disciplina | 610/.28 |
| Soggetto topico |
Medical care - United States
Technology assessment - United States Medical technology - United States - Evaluation Medical care Technology assessment Medical technology - Evaluation |
| ISBN |
1-280-22193-3
9786610221936 0-309-56306-2 0-585-14244-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Assessing Medical Technologies""; ""Copyright""; ""Acknowledgments""; ""Preface""; ""PROCEDURE FOR THE STUDY""; ""AUDIENCE FOR THE STUDY""; ""Contents""; ""Summary""; ""THE SCOPE OF U.S. MEDICAL TECHNOLOGY ASSESSMENT""; ""Varieties and Expense of Assessment""; ""Federal Government""; ""Drug Industry""; ""Medical Device Industry""; ""Other Private Sector Assessment Activities""; ""Lags in Assessment""; ""Recommendations""; ""METHODS OF MEDICAL TECHNOLOGY ASSESSMENT""; ""EFFECTS OF EVALUATION ON DIFFUSION OF TECHNOLOGY""; ""Diffusion and Its Determinants""
""Types of Evaluation That Precede Accepted Medical Practice"" ""Recommendations""; ""REIMBURSEMENT AND TECHNOLOGY ASSESSMENT""; ""Assessment in the New Era of Cost Containment""; ""Paying for Technology Assessment""; ""Recommendations""; ""MEDICAL TECHNOLOGY ASSESSMENT ABROAD""; ""Recommendations""; ""CONCLUSIONS AND RECOMMENDATIONS""; ""The Challenge""; ""Key Functions for Assessment""; ""Building a System""; ""Financing""; ""Recommendations""; ""1 Introduction""; ""POLIO""; ""SURGICAL PROCEDURE""; ""EXAMPLES OF TECHNOLOGY ASSESSMENT""; ""Electronic Fetal Monitoring"" ""Computed Tomography Scanning"" ""Drug Treatment for Hypertension""; ""Hysterectomy""; ""Medical Information System""; ""SOME LESSONS FROM THE EXAMPLES""; ""COMPREHENSIVE TECHNOLOGY ASSESSMENT""; ""DIFFERENT PARTIES, DIFFERENT AIMS IN ASSESSMENTS""; ""REFERENCES""; ""2 The Scope of U.S. Medical Technology Assessment""; ""AN OVERVIEW""; ""VARIETIES OF MEDICAL TECHNOLOGY ASSESSMENT""; ""NATIONAL EXPENDITURES FOR HEALTH RESEARCH AND DEVELOPMENT, CLINICAL TRIALS, AND TECHNOLOGY ASSESSMENT""; ""FEDERAL GOVERNMENT""; ""National Institutes of Health""; ""Office of Medical Applications of Research"" ""Food and Drug Administration"" ""Office of Technology Assessment""; ""Prospective Payment Assessment Commission""; ""Health Care Financing Administration""; ""National Center for Health Services Research and Health Care Technology Assessment""; ""Office of Health Technology Assessment""; ""National Center for Health Statistics""; ""Veterans Administration""; ""Centers for Disease Control""; ""Department of Defense""; ""DRUG INDUSTRY""; ""Drug Industry Research and Development""; ""Assessment of Drugs""; ""Expenditures for Drug Assessment""; ""MEDICAL DEVICE INDUSTRY"" ""Medical Device Industry Research and Development"" ""Assessment of Medical Devices""; ""Expenditures for Medical Device Assessment""; ""OTHER PRIVATE SECTOR ASSESSMENT ACTIVITIES""; ""Insurers""; ""Medical Associations""; ""Policy Research Groups""; ""Industry Associations""; ""Provider Institutions""; ""Academic Institutions""; ""Employers""; ""CONCLUSIONS""; ""RECOMMENDATIONS""; ""Assessment Concerns""; ""Coordination of Assessment Information""; ""Responsibility for Conduct of Assessments""; ""Evaluation of Assessment Programs""; ""Financial Support for Medical Technology Assessment""; ""Amount of Support"" |
| Record Nr. | UNINA-9910962422703321 |
| Washington, D.C., : National Academy Press, c1985 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Health care [[electronic resource] ] : national strategy needed to accelerate the implementation of information technology : testimony before the Committee on Government Reform, Subcommittee on Technology, Information Policy, Intergovernmental Relations and the Census, House of Representatives / / statement of David A. Powner
| Health care [[electronic resource] ] : national strategy needed to accelerate the implementation of information technology : testimony before the Committee on Government Reform, Subcommittee on Technology, Information Policy, Intergovernmental Relations and the Census, House of Representatives / / statement of David A. Powner |
| Autore | Powner David A |
| Pubbl/distr/stampa | [Washington, D.C.] : , : U.S. General Accounting Office, , [2004] |
| Collana | Testimony |
| Soggetto topico |
Public health administration - Information technology - United States
Medical technology - United States - Evaluation |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Health care |
| Record Nr. | UNINA-9910692501803321 |
Powner David A
|
||
| [Washington, D.C.] : , : U.S. General Accounting Office, , [2004] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Hope or hype [[electronic resource] ] : the obsession with medical advances and the high cost of false promises / / Richard A. Deyo, Donald L. Patrick
| Hope or hype [[electronic resource] ] : the obsession with medical advances and the high cost of false promises / / Richard A. Deyo, Donald L. Patrick |
| Autore | Deyo Richard A |
| Pubbl/distr/stampa | New York, : AMACOM, American Management Association, c2005 |
| Descrizione fisica | 1 online resource (352 p.) |
| Disciplina | 610/.28 |
| Altri autori (Persone) | PatrickDonald L |
| Soggetto topico |
Medical innovations - United States - Evaluation
Medical technology - United States - Evaluation Medical care - Technological innovations - United States - Evaluation Medical care - United States - Evaluation Medical innovations - Economic aspects - United States Medical technology - United States - Cost effectiveness Medical care - Technological innovations - United States - Cost effectiveness Medical care, Cost of - United States |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-281-12625-X
9786611126254 0-8144-2859-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured--film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Ineffective. inferior or needlessly costly new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making.
Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured--film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Useless, harmful, or marginal: popular treatments that caused unnecessary disability, dollar costs, or death -- Ineffective or inferior new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- Crossing the threshold: improving the transition from "experimental" to "standard care" -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making. |
| Record Nr. | UNINA-9910450176503321 |
|
Deyo Richard A
|
||
| New York, : AMACOM, American Management Association, c2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Hope or hype [[electronic resource] ] : the obsession with medical advances and the high cost of false promises / / Richard A. Deyo, Donald L. Patrick
| Hope or hype [[electronic resource] ] : the obsession with medical advances and the high cost of false promises / / Richard A. Deyo, Donald L. Patrick |
| Autore | Deyo Richard A |
| Pubbl/distr/stampa | New York, : AMACOM, American Management Association, c2005 |
| Descrizione fisica | 1 online resource (352 p.) |
| Disciplina | 610/.28 |
| Altri autori (Persone) | PatrickDonald L |
| Soggetto topico |
Medical innovations - United States - Evaluation
Medical technology - United States - Evaluation Medical care - Technological innovations - United States - Evaluation Medical care - United States - Evaluation Medical innovations - Economic aspects - United States Medical technology - United States - Cost effectiveness Medical care - Technological innovations - United States - Cost effectiveness Medical care, Cost of - United States |
| ISBN |
1-281-12625-X
9786611126254 0-8144-2859-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured--film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Ineffective. inferior or needlessly costly new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making.
Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured--film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Useless, harmful, or marginal: popular treatments that caused unnecessary disability, dollar costs, or death -- Ineffective or inferior new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- Crossing the threshold: improving the transition from "experimental" to "standard care" -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making. |
| Record Nr. | UNINA-9910783307403321 |
|
Deyo Richard A
|
||
| New York, : AMACOM, American Management Association, c2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Setting priorities for health technology assessment [[electronic resource] ] : a model process / / Molla S. Donaldson and Harold C. Sox, Jr., editors
| Setting priorities for health technology assessment [[electronic resource] ] : a model process / / Molla S. Donaldson and Harold C. Sox, Jr., editors |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1992 |
| Descrizione fisica | 1 online resource (162 p.) |
| Altri autori (Persone) |
DonaldsonMolla S
SoxHarold C |
| Soggetto topico |
Medical technology - United States - Evaluation
Technology assessment - United States |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-20319-6
9786610203192 0-309-57557-5 0-585-14909-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910456237803321 |
| Washington, D.C., : National Academy Press, 1992 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Setting priorities for health technology assessment [[electronic resource] ] : a model process / / Molla S. Donaldson and Harold C. Sox, Jr., editors
| Setting priorities for health technology assessment [[electronic resource] ] : a model process / / Molla S. Donaldson and Harold C. Sox, Jr., editors |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1992 |
| Descrizione fisica | 1 online resource (162 p.) |
| Altri autori (Persone) |
DonaldsonMolla S
SoxHarold C |
| Soggetto topico |
Medical technology - United States - Evaluation
Technology assessment - United States |
| ISBN |
1-280-20319-6
9786610203192 0-309-57557-5 0-585-14909-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910778507303321 |
| Washington, D.C., : National Academy Press, 1992 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Setting priorities for health technology assessment : a model process / / Molla S. Donaldson and Harold C. Sox, Jr., editors
| Setting priorities for health technology assessment : a model process / / Molla S. Donaldson and Harold C. Sox, Jr., editors |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1992 |
| Descrizione fisica | 1 online resource (162 p.) |
| Altri autori (Persone) |
DonaldsonMolla S
SoxHarold C |
| Soggetto topico |
Medical technology - United States - Evaluation
Technology assessment - United States |
| ISBN |
9786610203192
9781280203190 1280203196 9780309575577 0309575575 9780585149097 0585149097 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
SETTING PRIORITIES FOR HEALTH TECHNOLOGY ASSESSMENT -- Copyright -- Acknowledgments -- Contents -- Preface -- Summary -- RATIONALE -- METHODS OF PRIORITY SETTING -- GUIDING PRINCIPLES -- THE PROCESS PROPOSED BY THE IOM COMMITTEE -- Steps in the Process -- Seven Criteria -- Reassessment -- The Priority-Setting Cycle -- Human Resources Required to Implement the Process -- Publicly Available Products -- Topics for Which There is Insufficient Evidence to Conduct an Assessment Based on Review of the Literature -- RECOMMENDATIONS -- Recommendation 1 -- Recommendation 2 -- Recommendation 3 -- Recommendation 4 -- Recommendation 5 -- Recommendation 6 -- Recommendation 7 -- Recommendation 8 -- Recommendation 9 -- Recommendation 10 -- Recommendation 11 -- ADOPTION OF THE IOM'S PRIORITY-SETTING PROCESS BY OTHER ORGANIZATIONS -- Technology Assessment and Clinical Practice Guidelines -- POTENTIAL PROBLEMS WITH THE PRIORITY-SETTING PROCESS -- CONCLUDING REMARKS -- 1 Technology Assessment and the Need for Priority Setting -- EVOLUTION OF TECHNOLOGY ASSESSMENT TOWARD OUTCOMES, EFFECTIVENESS, AND APPROPRIATENESS RESEARCH -- The Effectiveness Initiative and Establishment of the Agency for Health Care Policy and Research -- The Office of Health Technology Assessment -- ORIGIN OF THE IOM STUDY -- Previous Pilot Study of Preliminary Model -- STUDY METHODS -- DEFINITIONS -- Medical Technology -- Technology Assessment -- Reassessment -- REPORT STRUCTURE -- SUMMARY -- APPENDIX: THE AGENCY FOR HEALTH CARE POLICY AND RESEARCH -- Center for Medical Effectiveness Research -- Office of the Forum for Quality and Effectiveness in Health Care -- Office of Science and Data Development -- Center for General Health Services Extramural Research and the Division of Technology and Quality Assessment -- Office of Health Technology Assessment -- OHTA Technology Assessments.
2 Methods for Priority Setting -- PRIORITY-SETTING PROCESSES USED BY ORGANIZATIONS -- Example 1: Health Care Financing Administration -- Bureau of Policy Development -- Health Care Financing Administration Physicians Panel -- Reevaluation or Assessment of Established Technologies -- Example 2: Private Sector-Pharmaceutical Industry -- Criteria for Assessment -- Criteria for Reassessment -- Internal Process of Priority Setting -- Example 3: Health Care Provider Organizations -- Example 4: Institute of Medicine/Council on Health Care Technology Pilot Study -- Example 5: Food and Drug Administration -- QUANTITATIVE MODELS FOR SETTING PRIORITIES -- Example 6: Technology Assessment Priority-Setting System -- Example 7: The Phelps-Parente Model -- SETTING PRIORITIES FOR SPENDING ON HEALTH SERVICES -- Example 8: Oregon Basic Health Services Act -- DISCUSSION -- Reactive and Implicit Processes -- Strengths and Weaknesses of Reactive Mechanisms -- The IOM/CHCT Process Compared with This IOM Study -- Analytic Models -- Strengths and Weaknesses of Analytic Models -- Need for a Comprehensive, Proactive Process for Priority Setting -- SUMMARY -- APPENDIX: MEDICARE COVERAGE DECISION MAKING -- 3 Guiding Principles -- BUILDING A MODEL PROCESS FOR SETTING PRIORITIES -- PROCESS BUILDING FOR OHTA -- The Process Must Reflect the Mission of OHTA -- Potential to Reduce Pain, Suffering, and Premature Death -- Potential to Reduce Inappropriate Health Care Expenditures -- Potential to Reduce Inequity and Inform Other Social Issues -- The Product of the Process Should Be Consistent with the Needs of Users -- The Process Must Be Efficient -- The Process Must Be Sensitive to the Environment in Which OHTA Operates -- SUMMARY -- 4 Recommendations for a Priority-Setting Process -- PREVIEW OF THE QUANTITATIVE MODEL -- ELEMENTS OF THE PROPOSED PRIORITY-SETTING PROCESS. Step 1. Selecting and Weighting Criteria Used to Establish Priorities -- Step 2. Identifying Candidate Conditions And Technologies -- Step 3. Winnowing the List of Candidate Conditions and Technologies -- Step 4. Data Gathering -- Step 5. Creating Criterion Scores -- Step 6. Computing Priority Scores -- Step 7. Review By Ahcpr National Advisory Council -- DETAILS OF THE PROPOSED PRIORITY-SETTING PROCESS -- Step 1. Selecting And Weighting The Criteria Used To Establish Priority Scores -- Selecting Criteria -- Weighting Criteria -- Step 2. Identifying Candidate Conditions And Technologies -- Step 3. Winnowing The List Of Candidate Conditions And Technologies -- Secondary Winnowing Processes -- Step 4. Data Gathering -- Specifying Alternative Technologies And Clinical Conditions -- Staff Summaries Of Clinical Conditions -- Step 5. Creating Criterion Scores -- General Points -- Criteria Recommended For The Iom Priority-Setting Model -- Criterion 1: Prevalence -- Criterion 2: Burden Of Illness -- Criterion 3: Cost -- Criterion 4: Variation In Rates Of Use -- Criterion 5: Potential Of The Results Of An Assessment To Change Health Outcomes -- Criterion 6: Potential Of The Results Of An Assessment To Change Costs -- Criterion 7: Potential of the Results of an Assessment to Inform Ethical, Legal, and Social Issues -- Criteria Rejected by the Committee -- Step 6. Computing Priority Scores -- Derivation of the Model -- Determining Whether Assessment is Desirable and Feasible -- Step 7. Review by Ahcpr National Advisory Council -- REASSESSMENT -- Role of Reassessment in the Complete Assessment Program -- Methods of Identifying Candidates for Reassessment -- Ongoing Tracking of Events Related to Previously Assessed Topics -- Evaluation of the Quality of Studies -- Ranking Candidates for Reassessment -- Final Steps after Establishing Priority for Reassessment. Sensitivity Analysis -- Cost Analysis -- SUMMARY -- APPENDIX 4.1: WINNOWING PROCESSES -- Intensity Rankings by Nominating Persons and Organizations -- Preliminary Ranking Processes -- Panel-Based Preliminary Weighting -- Comment -- APPENDIX 4.2: METHODOLOGIC ISSUES -- Properties of Logarithms -- Application to the Iom Model -- 5 Implementation Issues -- THE PRIORITY-SETTING CYCLE -- SETTING CRITERION WEIGHTS -- RESOURCES NEEDED TO IMPLEMENT THE PROCESS -- Technology Assessment Program Staff Requirements -- Priority-Setting Panel -- IMPLEMENTATION CONSIDERATIONS FOR OHTA AND OTHER ORGANIZATIONS -- Validity and Reliability -- Criteria -- Choosing-and Changing-Criteria -- Criterion Weights -- Availability of Data to Generate Criterion Scores -- Publicly Available Products -- WHEN THE SCIENTIFIC EVIDENCE IS INSUFFICIENT FOR ASSESSMENT -- Interim Statements -- Modeling -- SUMMARY -- 6 Recommendations and Conclusions -- REVIEW OF THE COMMITTEE'S RATIONALE AND RECOMMENDATIONS -- Recommendations -- Recommendation 1 -- Recommendation 2 -- Recommendation 3 -- Recommendation 4 -- Recommendation 5 -- Recommendation 6 -- Recommendation 7 -- Recommendation 8 -- Recommendation 9 -- Recommendation 10 -- Recommendation 11 -- REVIEW OF STEPS AND ISSUES IN IMPLEMENTATION -- Steps in a Priority-Setting Process -- Step 1. Selecting and Weighting the Criteria Used to Establish Priority Scores -- Step 2. Identifying Candidate Conditions and Technologies -- Step 3. Winnowing the List of Candidate Conditions and Technologies -- Step 4. Data Gathering -- Step 5. Creating Criterion Scores -- Step 6. Computing Priority Scores -- Step 7. Review of Priority Rankings by the National Advisory Council of the Agency for Health Care Policy and Research -- Resources for Implementation -- The Priority-Setting Cycle -- Publicly Available Products. Topics with Insufficient Evidence for Assessment Based on Review of the Literature -- ADOPTION OF THE IOM'S PRIORITY-SETTING PROCESS BY OTHER ORGANIZATIONS -- Technology Assessment and Clinical Practice Guidelines -- POTENTIAL PROBLEMS WITH THE PRIORITY-SETTING PROCESS -- Will a Numerical Priority Score Lead to Unrealistic Inferences About Priority? -- Does Codifying an Idealized Process Lead to Inflexibility? -- Will There Be a Bias Toward Choosing Topics That Are Quantifiable? -- CONCLUSION -- References -- Appendix A Pilot Test of the IOM Model -- METHODS -- Topics and Data for Priority Setting -- Criteria -- Criterion Weighting -- Criterion Scoring -- Convened Pilot -- Objective Criterion Scores. -- Mailed Pilot -- RESULTS -- Feasibility -- Improvements in the Model -- Comparison of Convened and Mailed Methods -- Criterion Weights -- Criterion Scores -- Priority Scores -- IMPLICATIONS OF THE PILOT TESTS FOR THE IOM MODEL -- Criterion Scores -- Appendix B Abbreviations. |
| Record Nr. | UNINA-9910957259603321 |
| Washington, D.C., : National Academy Press, 1992 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
